Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Angelini

Showing results (101-110 of 531) with videos related to

Pageof 54
Sort By:
Neuromuscular Disorders : NMD|January 1, 1992
Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patientsM Fanin, G A Danieli, L Vitiello, et al.
Neurology|March 1, 1984
Myoglobinuria and carnitine palmityltransferase (CPT) deficiency: studies with malonyl-CoA suggest absence of only CPT-IIC P Trevisan, C Angelini, L Freddo, et al.
Human Genetics|January 1, 1980
Duchenne muscular dystrophy: data from family studiesG A Danieli, M L Mostacciuolo, G Pilotto, et al.
Rivista Di Neurologia|May 1, 1982
[Preliminary study on the use of acetylcarnitine in patients with mental deterioration]G Testa, D Giaretta, A Pellegrini, et al.
Pediatric Research|December 1, 1980
Plasma and urine carnitine levels during developmentP A Battistella, L Vergani, F Donzelli, et al.
European Neurology|January 1, 1986
Malonyl-CoA abnormal inhibition of residual enzyme activity in carnitine palmitoyltransferase deficiencyC P Trevisan, C Angelini, L A Fiorellini, et al.
Annals of Neurology|January 1, 1980
Multisystem triglyceride storage disorder with impaired long-chain fatty acid oxidationC Angelini, M Philippart, C Borrone, et al.
Neuromuscular Disorders : NMD|January 1, 1996
Skeletal muscle sarcoplasmic reticulum phenotype in myotonic dystrophyE Damiani, C Angelini, M Pelosi, et al.
Neurology|March 14, 2001
Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathyM Fanin, E Pegoraro, C Matsuda-Asada, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
Implementation of an opioid management initiative by a state Medicaid programMaria M Garcia, Michael C Angelini, Tara Thomas, et al.
Pageof 54

Showing results (101-110 of 531) with videos related to

Sort By:
Pageof 54
Neuromuscular Disorders : NMD|January 1, 1992
Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patientsM Fanin, G A Danieli, L Vitiello, et al.
Neurology|March 1, 1984
Myoglobinuria and carnitine palmityltransferase (CPT) deficiency: studies with malonyl-CoA suggest absence of only CPT-IIC P Trevisan, C Angelini, L Freddo, et al.
Human Genetics|January 1, 1980
Duchenne muscular dystrophy: data from family studiesG A Danieli, M L Mostacciuolo, G Pilotto, et al.
Rivista Di Neurologia|May 1, 1982
[Preliminary study on the use of acetylcarnitine in patients with mental deterioration]G Testa, D Giaretta, A Pellegrini, et al.
Pediatric Research|December 1, 1980
Plasma and urine carnitine levels during developmentP A Battistella, L Vergani, F Donzelli, et al.
European Neurology|January 1, 1986
Malonyl-CoA abnormal inhibition of residual enzyme activity in carnitine palmitoyltransferase deficiencyC P Trevisan, C Angelini, L A Fiorellini, et al.
Annals of Neurology|January 1, 1980
Multisystem triglyceride storage disorder with impaired long-chain fatty acid oxidationC Angelini, M Philippart, C Borrone, et al.
Neuromuscular Disorders : NMD|January 1, 1996
Skeletal muscle sarcoplasmic reticulum phenotype in myotonic dystrophyE Damiani, C Angelini, M Pelosi, et al.
Neurology|March 14, 2001
Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathyM Fanin, E Pegoraro, C Matsuda-Asada, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
Implementation of an opioid management initiative by a state Medicaid programMaria M Garcia, Michael C Angelini, Tara Thomas, et al.
Pageof 54